Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study

Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination. We aimed to assess genitourinary cancer patients' perceptions of the vaccines as well as barriers and influencers of decision-making through the completion of a questionnaire. While vaccine-associated concerns were observed, most patients with genitourinary cancers were willing to receive the vaccine. Moving forward, differing strategies could be considered to enhance patient education on the utility of vaccination in the setting of cancer and beyond.

Automated summary

Through a questionnaire, we assessed genitourinary cancer patients' perceptions of COVID-19 vaccines and identified potential barriers and influencers in the decision-making process. Despite some concerns, a majority of patients with genitourinary cancers were willing to receive the vaccine. Various strategies could be implemented to improve patient education on the benefits of vaccination in the context of cancer and beyond.